Head-to-Head Comparison of 68Ga-NODAGA-JR11 and 68Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study

Zefang Lin; Wenjia Zhu; Jiaying Zhang; Weibing Miao; Shaobo Yao; Li Huo

doi:10.2967/jnumed.122.264890

Research ArticleClinical Investigation

Head-to-Head Comparison of ⁶⁸Ga-NODAGA-JR11 and ⁶⁸Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study

Zefang Lin, Wenjia Zhu, Jiaying Zhang, Weibing Miao, Shaobo Yao and Li Huo

Journal of Nuclear Medicine September 2023, 64 (9) 1406-1411; DOI: https://doi.org/10.2967/jnumed.122.264890

Zefang Lin

1Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou, China; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wenjia Zhu

2Nuclear Medicine Department, State Key Laboratory of Complex Severe and Rare Diseases, Center for Rare Diseases Research, and Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jiaying Zhang

1Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou, China; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Weibing Miao

1Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou, China; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shaobo Yao

1Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou, China; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Li Huo

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Article Information

vol. 64 no. 9 1406-1411

DOI

https://doi.org/10.2967/jnumed.122.264890

PubMed

37474267

Published By

Society of Nuclear Medicine

Print ISSN

0161-5505

Online ISSN

2159-662X

History

Received for publication September 7, 2022
Revision received April 20, 2023
Published online September 1, 2023.

Article Versions

previous version (July 20, 2023 - 06:43).
You are viewing the most recent version of this article.

Author Information

Zefang Lin*,¹,
Wenjia Zhu*,²,
Jiaying Zhang¹,
Weibing Miao¹,
Shaobo Yao¹ and
Li Huo²

¹Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou, China; and
²Nuclear Medicine Department, State Key Laboratory of Complex Severe and Rare Diseases, Center for Rare Diseases Research, and Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China

For correspondence or reprints, contact Li Huo (huoli{at}pumch.cn) or Shaobo Yao (yaoshaobo008{at}163.com).

↵* Contributed equally to this work.

View Full Text

Statistics from Altmetric.com

Cited By...

16 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Gallium-68 labeled somatostatin receptor antagonist PET/CT in over 500 patients with neuroendocrine neoplasms: experience from a single center in China

Meixi Liu, Yuejuan Cheng, Chunmei Bai, Hong Zhao, Ru Jia, Jingci Chen, Wenjia Zhu, Li Huo

European Journal of Nuclear Medicine and Molecular Imaging 2024 51 7
Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update

Martina Di Franco, Lucia Zanoni, Emilia Fortunati, Stefano Fanti, Valentina Ambrosini

Current Oncology Reports 2024 26 5
Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NOTA-LM3 and head-to-head comparison with [68Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial

Meixi Liu, Chao Ren, Haiqiong Zhang, Yuwei Zhang, Zhenghai Huang, Ru Jia, Yuejuan Cheng, Chunmei Bai, Qiang Xu, Wenjia Zhu, Li Huo

European Journal of Nuclear Medicine and Molecular Imaging 2024 51 12
Head-to-Head Comparison of SSTR Antagonist [68Ga]Ga-DATA5m-LM4 with SSTR Agonist [68Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study

Rahul Viswanathan, Sanjana Ballal, Madhav P. Yadav, Frank Roesch, Parvind Sheokand, Swayamjeet Satapathy, Madhavi Tripathi, Shipra Agarwal, Euy Sung Moon, Chandrasekhar Bal

Pharmaceuticals 2024 17 3
A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study

Jieling Zheng, Guochang Wang, Qian Ru, Yun Yang, Li Su, Wenlong Lv, Chunlin Ke, Peirong Wang, Xiaohui Liu, Li Zhang, Feng Liu, Weibing Miao

European Journal of Nuclear Medicine and Molecular Imaging 2024 51 11
Clinical Intricacies and Advances in Neuroendocrine Tumors: An Organ-Based Multidisciplinary Approach

Luigi Asmundo, Valentina Ambrosini, Mark A. Anderson, Stefano Fanti, William R. Bradley, Davide Campana, Amirkasra Mojtahed, Ryan Chung, Shaunagh Mcdermott, Subba Digumarthy, Stephan Ursprung, Konstantin Nikolau, Florian J. Fintelmann, Michael Blake, Carlos Fernandez-del Castillo, Motaz Qadan, Ankur Pandey, Jeffrey W. Clark, Onofrio A. Catalano

Journal of Computer Assisted Tomography 2024 48 4
May the Nuclear Medicine be with you! Neuroendocrine tumours and the return of nuclear medicine

Ozgul Ekmekcioglu, Simon Hughes, Wolfgang P Fendler, Fred Verzijlbergen, Grace Kong, Michael S Hofman

European Journal of Nuclear Medicine and Molecular Imaging 2024 52 1
Neuroendocrine Tumors

Christopher Sakellis, Heather A. Jacene

PET Clinics 2024 19 3
Scalable droplet-based radiosynthesis of [18F]fluorobenzyltriphenylphosphonium cation ([18F]FBnTP) via a “numbering up” approach

Yingqing Lu, Jeffrey Collins, Kuo-Shyan Lin, R. Michael van Dam

Lab on a Chip 2024 24 4
2024 Medicinal Chemistry Reviews

Benjamin D. Sellers, Brian R. Hearn, Katerina Leftheris*, Jennifer X. Qiao

2024 59

Article usage

Article usage: July 2023 to February 2025

	Abstract	Full	Pdf
Jul 2023	2049	106	62
Aug 2023	826	21	15
Sep 2023	1167	46	51
Oct 2023	497	54	25
Nov 2023	112	128	42
Dec 2023	57	87	34
Jan 2024	129	161	27
Feb 2024	59	233	23
Mar 2024	28	147	41
Apr 2024	32	143	54
May 2024	30	71	31
Jun 2024	23	97	37
Jul 2024	24	242	54
Aug 2024	20	251	75
Sep 2024	22	120	45
Oct 2024	16	88	44
Nov 2024	23	72	37
Dec 2024	13	71	47
Jan 2025	15	54	41
Feb 2025	28	120	44

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 64, Issue 9

September 1, 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Head-to-Head Comparison of 68Ga-NODAGA-JR11 and 68Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Head-to-Head Comparison of ⁶⁸Ga-NODAGA-JR11 and ⁶⁸Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study

Zefang Lin, Wenjia Zhu, Jiaying Zhang, Weibing Miao, Shaobo Yao, Li Huo

Journal of Nuclear Medicine Sep 2023, 64 (9) 1406-1411; DOI: 10.2967/jnumed.122.264890

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Head-to-Head Comparison of ⁶⁸Ga-NODAGA-JR11 and ⁶⁸Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study

Zefang Lin, Wenjia Zhu, Jiaying Zhang, Weibing Miao, Shaobo Yao, Li Huo

Journal of Nuclear Medicine Sep 2023, 64 (9) 1406-1411; DOI: 10.2967/jnumed.122.264890

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

somatostatin receptor antagonist
68Ga-NODAGA-JR11
68Ga-DOTATATE
neuroendocrine tumor
PET/CT

Main menu

User menu

Search

Head-to-Head Comparison of ⁶⁸Ga-NODAGA-JR11 and ⁶⁸Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study

Article Information

Article Versions

Author Information

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: July 2023 to February 2025

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords